Anzeige
Mehr »
Dienstag, 07.10.2025 - Börsentäglich über 12.000 News
Golden Cross könnte Australiens nächste Goldentdeckung in der Pipeline haben!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PTXJ | ISIN: CA74319B5027 | Ticker-Symbol:
NASDAQ
07.10.25 | 16:28
5,980 US-Dollar
+4,55 % +0,260
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PROFOUND MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
PROFOUND MEDICAL CORP 5-Tage-Chart

Aktuelle News zur PROFOUND MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15:06Profound Medical achieves record prelim revenue for third quarter1
14:07Profound Medical Corp. - 8-K, Current Report2
13:48Profound Medical Corp.: Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter27TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable...
► Artikel lesen
PROFOUND MEDICAL Aktie jetzt für 0€ handeln
25.09.Raymond James bestätigt "Outperform"-Rating für Profound Medical2
25.09.Profound Medical stock rating reiterated at Outperform by Raymond James3
23.09.Profound Medical Corp (2): Profound Medical talks Tulsa use by Texas Prostate1
23.09.Profound Medical Corp.: Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment2
19.08.Profound Medical is a buy, Leede says3
15.08.Profound Medical targets 70-75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence2
14.08.Profound Medical Corp.: Profound Medical Announces Second Quarter 2025 Financial Results146TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable...
► Artikel lesen
14.08.Profound Medical Corp. - 8-K, Current Report1
25.07.Profound Medical Corp (2): Profound Medical to release Q2 results Aug. 141
10.06.Profound Medical Corp (2): Profound completes first BPH treatment with Tulsa-Pro1
10.06.Profound Medical Corp.: Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction1
04.06.Profound Medical Corp (2): Profound Medical names ex-NFLer Wheeler as ambassador2
04.06.Profound Medical Corp. - 8-K, Current Report1
04.06.Profound Medical Corp.: Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO1
15.05.Profound Medical Corp (2): Profound Medical shareholders approve AGM resolutions1
14.05.Profound Medical Corp.: Profound Medical Annual General and Special Meeting of Shareholders Voting Results125TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) ("Profound" or the "Company") is pleased to announce the voting results from its Annual General and Special...
► Artikel lesen
09.05.Profound Medical stock rating downgraded at Raymond James1
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1